번호 | 제목 | 첨부파일 | 등록일 | 조회 |
---|---|---|---|---|
79 | A guide to risk assessments for cleanroom containment | 2024.05.14 | 356 | |
78 | WHO issues guidance on nitrosamine controls in drug manufacturing | 2024.05.14 | 311 | |
77 | Key Considerations For Emerging Companies When Selecting Packaging Co... | 2024.04.08 | 303 | |
76 | FDA proposes rule for difficult-to-compound drugs, drug categories | 2024.04.08 | 306 | |
75 | Should you automate your processes in pharmaceutical sterilisation? | 2024.04.08 | 363 | |
74 | Navigating the complexities of cleanrooms and sterile spaces | 2024.04.08 | 250 | |
73 | How well does technology safeguard pharmaceutical purified water from... | 2024.04.08 | 234 | |
72 | Master Protocols for Drug and Biological Product Development | 2024.04.08 | 262 | |
71 | Where to find GDP Certificates and Wholesale Distributor Authorizatio... | 2024.04.08 | 253 | |
70 | Single-use technology propelling upstream bioprocessing market expans... | 2024.03.05 | 371 |